A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.
Conditions: Agitation,Psychomotor; Disruptive Behavior; Dementia; Alzheimer Disease Interventions: Drug: Medical Cannabis; Drug: Placebo Oil Sponsors: M. H MediCane Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Cognitive Leisure and Preclinical Alzheimer's Disease: Exploring Neural Mechanisms
Conditions: Cognitive Dysfunction Interventions: Other: Relationship of the cognitive leisure activity levels, cognitive function, and MRI characteristics. Sponsors: Yuanjiao Yan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Spatial and Ocular Trajectories for the Early Diagnosis of Alzheimer's Disease.
Conditions: Alzheimer Disease; Aging Interventions: Diagnostic Test: Cognitive assessment; Other: Questionnaires; Device: Spatial navigation task with eye-tracking.; Biological: Blood sampling Sponsors: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease
Conditions: Alzheimer Disease Interventions: Behavioral: Belly-focus meditation; Behavioral: Belly-focus meditation with slow breathing Sponsors: University of Southern California; University of California, Irvine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study
Conditions: Neurodegenerative Diseases; Alzheimer Disease; Frontotemporal Dementia; Lewy Body Disease; Vascular Dementia; Parkinson Disease; Progressive Supranuclear Palsy; Corticobasal Degeneration; Multiple System Atrophy; Amyotrophic Lateral Sclerosis; Huntington Disease Sponsors: Kuopio University Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease
Conditions: Healthy Volunteers; Down Syndrome; Alzheimer ' s Disease Interventions: Drug: Leucettinib-21 Sponsors: Perha Pharmaceuticals; France 2030 program; European Innovation Council; Fondation J érôme Lejeune Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
NYSCF Scientific Discovery Biobank
Conditions: ALS; Amyotrophic Lateral Sclerosis; Alzheimer Disease; Alzheimer Disease, Early Onset; Alzheimer Disease, Late Onset; Batten Disease; Corticobasal Degeneration; Dementia; Frontotemporal Dementia; Huntington Disease; Lewy Body Disease; Multiple Sclerosis; Multiple System Atrophy; Parkinson Disease; Parkinson ' s Disease and Parkinsonism; Progressive Supranuclear Palsy; INAD; Diabetes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Macular Degeneration; Ovarian Cancer; Cervical Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer; PTSD; Post Traumatic Stress Disorder Interventions: Othe...
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Memory Enhancement Using Transcranial Alternating Current Stimulation
Conditions: Alzheimer Disease; Mild Cognitive Impairment Interventions: Device: Gamma (40 Hz) tACS at the precuneus region; Device: Sham tACS at the precuneus region Sponsors: Amsterdam UMC, location VUmc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Design of Personalised supplemenTs Based on the Gut micRobiota Through Artificial Intelligence for Alzheimer's Patients
Conditions: Alzheimer Disease; Gut Microbiota Interventions: Dietary Supplement: Personalized diet; Dietary Supplement: Dietary counseling Sponsors: Universidad Complutense de Madrid; Hospital Cl ínico Universitario Virgen de la Arrixaca; Universidad Europea de Madrid Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
Conditions: Alzheimer ' s Disease Interventions: Drug: SHR-1707; Drug: SHR-1707 placebo Sponsors: Shanghai Hengrui Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
Conditions: Alzheimer Disease Interventions: Drug: NTRX-07; Drug: Placebo Sponsors: NeuroTherapia, Inc.; CRU Early Phase Unit Kistarcsa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
Conditions: Alzheimer ' s Disease Psychosis Interventions: Drug: ACP-204 Sponsors: ACADIA Pharmaceuticals Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults
Conditions: Subjective Cognitive Decline; Alzheimer Dementia Interventions: Diagnostic Test: Cognigram; Diagnostic Test: Subjective cognitive decline questionnaire (SCD-Q); Diagnostic Test: blood-based biomarkers; Diagnostic Test: ki:elements digital speech biomarker for cognition (ki:e SB-C) Sponsors: Ludwig-Maximilians - University of Munich; ki:elements; Hoffmann-La Roche; Eisai Limited; Johanniter-Unfall-Hilfe e.V.; University of Southern California Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Conditions: Moderate Alzheimer Disease Interventions: Biological: SNK01; Other: Placebo Sponsors: NKGen Biotech, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Phase I/IIa Study of SNK01 in Participants With Moderate Alzheimer's Disease
Conditions: Moderate Alzheimer Disease Interventions: Biological: SNK01; Other: Placebo Sponsors: NKGen Biotech, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
